Skip to content

The usefulness of high-concenrate magnesium citrate solution for colonic preparation before colonoscopy

The usefulness of high-concenrate magnesium citrate solution for colonic preparation before colonoscopy - The usefulness of high-concenrate magnesium citrate solution for colonic preparation before colonoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022993
Enrollment
20
Registered
2016-07-03
Start date
2016-07-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appropriate indication to colonoscopy

Interventions

high-concentrate magnesium citrate administration

Sponsors

Takarazuka Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)The outpatient whom colonoscopic examination is performed in (2)The patients that an inclusion agreement is obtained in response to the explanation that is enough for this study by a chief physician

Exclusion criteria

Exclusion criteria: (1)The patients who are contraindicated to colonoscopic examination * The patients with the intestinal perforation, acute bleeding, general debility * The patients with the inflammatory disorder with ulcerative colitis, Crohn's disease * The patients (including colorectal cancer and the benign disease) with the intestinal stenosis * The patients with a history of stomach or the intestinal resection * The patients with active cancer * Including the treatment for other carcinomas, it is the patient with a history of the radiotherapy to the upper quadrant * With the pregnant likelihood during the pregnancy or the women whom we are nursing * The patients considered that we are complicated with psychosis or psychiatric symptoms, and the participation in study is difficult * In addition, the patients who are found with complications serious (2)The patients who are contraindicated to a use drug * To gastrointestinal tract with obstruction or the patients whom there is the suspicion and the patients with the induration service with serious case * The patients with suspected acute abdomen * The patients (abnormal value of the Cr) with the renal failure * The patients with toxic megacolon * It is the patient with a history of hypersensitivity to the ingredient of the use drug (3)In addition, the patients who judged that doctor attending was inadequate

Design outcomes

Primary

MeasureTime frame
Degree of colon cleansing: Bowel cleansing was assessed by colonoscopist. The degree of colon cleansing was recorded for each bowel segment (rectum, sigmoid colon, descending colon, transverse colon, ascending colon/rectum ). Each segments was recorded into 4 categories (excellent, good, poor, inadequate).

Secondary

MeasureTime frame
Acceptability. Adverse events; Any adverseevents related to bowel preparation(abdominal pain, nausea, vomiting, etc) were reported by the endoscopic technician. All participants were monitored for adverse events during colonoscopy.

Countries

Japan

Contacts

Public ContactHironori Tanaka

Takarazuka Municipal Hospital Department of Gastroenterology and Hepatology

hironori4951@hotmail.co.jp0797-87-1171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026